![Einsatzfahrzeug: EF-34013 - MB Sprinter 214 - DHuFüKW (a.D.) - BOS-Fahrzeuge - Einsatzfahrzeuge und Wachen weltweit Einsatzfahrzeug: EF-34013 - MB Sprinter 214 - DHuFüKW (a.D.) - BOS-Fahrzeuge - Einsatzfahrzeuge und Wachen weltweit](https://files.bos-fahrzeuge.info/vehicles/photos/2/2/a/e/52259-large.jpg)
Einsatzfahrzeug: EF-34013 - MB Sprinter 214 - DHuFüKW (a.D.) - BOS-Fahrzeuge - Einsatzfahrzeuge und Wachen weltweit
Fucik, Julius : Florentiner Marsch op.214 für Streichquartett und Kontrabaß ad lib. - bei Musikforum Demond kaufen
AdAlta's inhaled fibrosis drug AD-214 passes first development milestone with successful nebulisation | ASX:1AD
![Roman Provincial AD 214-215 CARACALLA AR Tetradrachm. EF-/EF. Antioch mint. Eagle over Leg and Thigh. | MA-Shops Roman Provincial AD 214-215 CARACALLA AR Tetradrachm. EF-/EF. Antioch mint. Eagle over Leg and Thigh. | MA-Shops](https://img.ma-shops.de/an/pic/805_rpsm66.jpg)
Roman Provincial AD 214-215 CARACALLA AR Tetradrachm. EF-/EF. Antioch mint. Eagle over Leg and Thigh. | MA-Shops
![AD-214 antibody targeting CXC4 reduces fibrosis in murine model of chronic kidney disease | BioWorld AD-214 antibody targeting CXC4 reduces fibrosis in murine model of chronic kidney disease | BioWorld](https://www.bioworld.com/ext/resources/Stock-images/Therapeutic-topics/Nephrology/Kidneys3.png?1637092659)
AD-214 antibody targeting CXC4 reduces fibrosis in murine model of chronic kidney disease | BioWorld
![AdAlta to advance improved lung fibrosis therapy, AD-214 - AdAlta - Developing i-body drugs to treat fibrotic diseases AdAlta to advance improved lung fibrosis therapy, AD-214 - AdAlta - Developing i-body drugs to treat fibrotic diseases](http://adalta.com.au/wp-content/uploads/2018/04/AD-114-to-AD-214-image-1024x416.jpg)
AdAlta to advance improved lung fibrosis therapy, AD-214 - AdAlta - Developing i-body drugs to treat fibrotic diseases
![New AD-214 Data Links Phase I Results With Efficacy; De-Risks Clinical Dosing Schedule - EmergingGrowth.com New AD-214 Data Links Phase I Results With Efficacy; De-Risks Clinical Dosing Schedule - EmergingGrowth.com](https://emerginggrowth.com/wp-content/uploads/2023/07/shutterstock_2197072529.jpg)